TCG and Pharmaceutical Product Licensing
Early stage pharmaceutical product licensing often offers the quickest path to revenues and 
market success, especially in times of industry change, regulatory uncertainty and risk-adverse investors. At the same time, companies planning to out-license must completely understand how the market will value the product after FDA approval, and then develop the drug in a way that licensing partners can see a clear path to commercialization and reasonable returns on their investments. Successful out-licensing demands a highly collaborative approach with business development professionals who have commercialization experience, along with deal experience and an abundance of personal relationships and contacts in the industry. These are the critical factors that TCG brings to your team.
To read Case Studies outlining TCG’s successful track record of doing deals for small to mid-sized pharmaceutical companies, see below:
- Unlocking Early Value in a Development Stage Therapeutics Company
- Creative Financing for Product Development for an Early Stage Biotech Company
- Creative R&D Partnering Options for an Early Stage Biotech Company
- Opportunity Assessment for an M & A Project
- Assessing the Market Potential for a Novel Active Ingredient
- Accelerating Time-to-Market in an Early Stage Company Through Licensing
